Archives
-
Linarin Arrests NSCLC Cells With Cyclin A2 Downregulation
2026-09-23
A 2026 study reports that Linarin, a Herba Patriniae component, suppresses NSCLC cell growth while promoting G0/G1 arrest, senescence, and apoptosis in two cell models with different p53 status. EdU staining helped assess DNA synthesis, while the findings link these effects to lower levels of cyclin A2, cyclin B1, and CHEK1 without establishing that any one target directly causes the full response.
-
ECL Western Blotting Substrate: Workflow Guide
2026-09-23
ECL Western Blotting Substrate (SKU K2187) provides luminol-based, nonradioactive detection of HRP-labeled proteins on immunoblots using X-ray film or CCD imaging. It is intended for HRP Western blot workflows and should not be substituted for fluorescent, alkaline phosphatase, or radioisotopic detection systems.
-
Nintedanib: A Biomarker-Aware RTK Assay Strategy
2026-09-22
Nintedanib (BIBF 1120) connects angiokinase biology with genotype-aware cancer research. This guide explains how ATRX status, receptor selectivity, and assay design can sharpen studies of angiogenesis inhibition, glioma vulnerability, and translational drug response.
-
Exosomal HMGB1 in Lupus Nephritis Endothelial Injury
2026-09-22
The reference study identifies podocyte-derived exosomes carrying HMGB1 as a mechanistic link between lupus nephritis and glomerular endothelial cell injury, with TRIM27 positioned as an important downstream mediator. Its combined patient, cellular, and mouse experiments show how pharmacological suppression of vesicle release and genetic manipulation of HMGB1 or TRIM27 can dissect podocyte–endothelial communication.
-
Serial mRNA Delivery for Human T Cell Engineering
2026-09-21
Ramamurthy and colleagues show that DOTAP/DOPE lipid nanoparticles enable repeated mRNA delivery to primary human T cells while preserving substantially more viable cells than electroporation. The work establishes serial LNP transfection as a practical platform for iterative CAR and other payload engineering, while also defining important questions about delivery efficiency, cell survival, and intracellular trafficking.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-09-21
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody detects goat IgG primary antibodies in fluorescence-based ICC/IF, IHC, flow cytometry, and ELISA workflows. It should not be used as a general secondary reagent for non-goat primaries, non-IgG targets, or unvalidated live-cell applications.
-
Serial mRNA Delivery for Human T Cell Engineering
2026-09-20
Ramamurthy and colleagues show that DOTAP/DOPE lipid nanoparticles can support repeated mRNA delivery to primary human T cells while preserving substantially more viable cells than electroporation. The study establishes serial LNP transfection as a practical platform for iterative CAR and other payload engineering, while leaving the underlying trafficking mechanisms open for further investigation.
-
Brefeldin A Workflows for ER Stress and Trafficking
2026-09-19
Brefeldin A connects ER–Golgi trafficking disruption with measurable ER stress, secretion defects, and cancer-cell phenotypes. This practical guide shows how to build dose–time experiments, separate trafficking effects from nonspecific toxicity, and use BFA to investigate protein quality control.
-
Dynasore Workflow for Dynamin-Dependent Endocytosis
2026-09-18
Dynasore is a reversible dynamin GTPase inhibitor for separating vesicle scission from downstream trafficking, viral entry, and receptor signaling. This practical guide covers dose planning, uptake assays, neuronal applications, controls, and troubleshooting for more interpretable endocytosis research.
-
L-Ornithine: Designing Liver–Brain Metabolic Assays
2026-09-18
L-Ornithine is more than a urea cycle intermediate: it is a controllable variable for connecting hepatic nitrogen disposal with astrocyte metabolism. This article translates recent liver–brain axis findings into practical assay design, controls, and interpretation strategies.
-
5-Azacytidine Workflow for Epigenetic Assays
2026-09-17
Build a reproducible 5-Azacytidine workflow that separates DNA demethylation, cytotoxicity, and durable cancer-cell dormancy. Practical dosing, fresh-solution handling, orthogonal readouts, and troubleshooting guidance help translate DNMT inhibition into interpretable results.
-
Busulfan: DNA Alkylating Agent for Cell Models
2026-09-17
Busulfan is a DNA alkylating agent used to model DNA damage, senescence induction in WI38 fibroblasts, and germ-cell depletion. In a recent mouse lineage-tracing study, busulfan-induced ovarian injury did not produce evidence of postnatal neo-oogenesis.
-
Clathrin-Mediated Entry of Type III GCRV
2026-09-16
Wang et al. used pharmacological inhibitors, transmission electron microscopy, and quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, clathrin-mediated, pH-sensitive pathway. The study provides a useful experimental framework for distinguishing viral entry mechanisms while highlighting the need for orthogonal validation of inhibitor-based conclusions.
-
Cholecystokinin octapeptide ammonium Workflows
2026-09-16
Build more reliable neurobehavioral, receptor-signaling, apoptosis, immune, and cardiac peptide assays with CCK-8 ammonium. This guide combines a zebrafish anxiety model with practical formulation, dosing, controls, and troubleshooting strategies for context-dependent CCK1R and CCK2R biology.
-
15-PGDH Inhibition and Muscle Recovery During Weight Loss
2026-09-15
The reference study identifies 15-PGDH inhibition as a strategy for improving skeletal muscle repair and strength recovery during semaglutide-associated weight loss. In obese mice, combining a 15-PGDH inhibitor with semaglutide enhanced muscle stem cell activity and regenerated myofiber growth without reducing the weight-loss effect of the GLP-1 receptor agonist.